ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1199

Interstitial Lung Disease in Systemic Autoimmune Rheumatic Diseases (SARDs): Radiologic and Histologic Correlations

Darya S. Jalaledin1, Aidan pye2, Angela Chang2, Navid Saleh2, Saud AlHajeri3, Beatrice Daviault4, Arusa Shah5, Sabrina Hoa6, Océane Landon-Cardinal7, Alec Yu2, Robert Levy8, Jennifer Wilson9, Charles Poirier4, James Choi2, John Yee2, Hyein Kim2 and Kun Huang10, 1Université de Montréal, Saint-Lambert, QC, Canada, 2University of British Columbia, VANCOUVER, BC, Canada, 3University of British Columbia, Vancouver, Canada, 4University of Montreal, Montreal, QC, Canada, 5University of Montreal, Montreal, BC, Canada, 6University of Montreal, Brossard, QC, Canada, 7Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada, 8University of British Columbia, Deerfield, IL, 9UBC, Vancouver, BC, Canada, 10University of British Columbia, Vancouver, Surrey, BC, Canada

Meeting: ACR Convergence 2025

Keywords: interstitial lung disease, Myopathies, Myositis, rheumatoid arthritis, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1191–1220) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic autoimmune rheumatic diseases (SARDs) are a major cause of interstitial lung disease (ILD), with high prevalence in inflammatory idiopathic myopathy (IIM), systemic sclerosis (SSc), and rheumatoid arthritis (RA). In clinical practice, ILD assessment relies primarily on high-resolution CT (HRCT), as surgical lung biopsy is infrequently performed in SARDs-ILD. This study aims to evaluate the correlation between radiologic patterns at diagnosis and histopathologic findings in explanted lung tissue from SARDs-ILD patients undergoing lung transplantation.

Methods: Patients with ILD secondary to IIM, SSc, or RA who underwent lung transplantation between January 1, 2014 and April 30, 2024 at Vancouver General Hospital and between January 1, 2012 and December 31, 2024 at the Centre hospitalier de l’Université de Montréal were included. Agreement between HRCT and histologic diagnoses was assessed using kappa (κ) statistics with predefined coefficient weights: complete agreement (same diagnoses, κ=1), partial agreement (overlapping terms, for example, NSIP vs. NSIP/UIP κ=0.5), or no agreement (different terms, κ=0). The HRCT-histopathology relationship was visualized using an Alluvial chart (Flourish, UK).

Results: The study included 70 patients (18 IIM, 24 SSc, and 28 RA) (Table 1). RA patients were older at transplant, more likely to have a smoking history, and less likely to be female compared to IIM and SSc. IIM patients were more likely to require emergency lung transplant. At initial presentation, nonspecific interstitial lung disease (NSIP) was the predominant HRCT pattern in IIM (55.6%) and SSc (75%) patients, while usual interstitial lung disease (UIP) was most common in RA (57.1%) (Table 2). On explant pathology, NSIP remained the primary tissue diagnosis in SSc (62.5%), followed by mixed NSIP/UIP (20.8%) and UIP (12.5%). In RA, UIP was the most frequent histopathologic pattern (50%), followed by mixed NSIP/UIP (25%) and NSIP (17.9%) (Table 2). Cohen’s κ analysis with custom coefficient weight demonstrated moderate agreement between HRCT and histology for SSc (κ = 0.42, p=0.02) and RA (κ = 0.46, p=0.002). In contrast, IIM showed insignificant correlation (κ = 0.14, p=0.4), with explant pathology distributed across all six diagnostic patterns. Notably, 50% of IIM patients undergoing transplant had anti-MDA5 dermatomyositis with rapidly progressive ILD clinically, and either diffuse alveolar damage (DAD) or unclassifiable end stage fibrosis on explant.

Conclusion: This study demonstrates moderate radiologic-histologic correlation in SSc- and RA-associated ILD. However, IIM-ILD shows significant histopathologic heterogeneity that poorly correlates with HRCT patterns, particularly in anti-MDA5 positive patients who uniformly exhibited rapidly progressive ILD with diffuse alveolar damage. The major limitation of the study is that explant lungs often have extensive damage from chronic disease and infections, obscuring the original histologic pattern. Despite the limitation, these findings highlight the dynamic radiologic and histologic evolution of ILD in IIM-ILD.

Supporting image 1Table 1. Baseline patient demographics pre-transplant.

Supporting image 2Table 2. Radiologic pattern at ILD diagnosis and histologic findings in explanted lungs.

Supporting image 3Figure 1. Alluvial chart for correlation between radiologic patterns and histopathologic findings in IIM (A), SSc (B), and RA (C).


Disclosures: D. S. Jalaledin: None; A. pye: None; A. Chang: None; N. Saleh: None; S. AlHajeri: None; B. Daviault: None; A. Shah: None; S. Hoa: None; O. Landon-Cardinal: None; A. Yu: None; R. Levy: None; J. Wilson: None; C. Poirier: None; J. Choi: None; J. Yee: None; H. Kim: Fresenius Kabi, 6; K. Huang: AbbVie/Abbott, 6, Fresenius Kabi, 6, Novartis, 6, Pfizer, 5.

To cite this abstract in AMA style:

S. Jalaledin D, pye A, Chang A, Saleh N, AlHajeri S, Daviault B, Shah A, Hoa S, Landon-Cardinal O, Yu A, Levy R, Wilson J, Poirier C, Choi J, Yee J, Kim H, Huang K. Interstitial Lung Disease in Systemic Autoimmune Rheumatic Diseases (SARDs): Radiologic and Histologic Correlations [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/interstitial-lung-disease-in-systemic-autoimmune-rheumatic-diseases-sards-radiologic-and-histologic-correlations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/interstitial-lung-disease-in-systemic-autoimmune-rheumatic-diseases-sards-radiologic-and-histologic-correlations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology